News

Portfolio Companies
in the News

Sound Blade Medical Closes $16.5 Million Series A Financing to Advance the Development of Innovative Handheld Histotripsy Therapy

January 29, 2025

Medtronic inks distribution deal with Contego with option to buy firm

January 13, 2025

Hologic Completes Acquisition of Gynesonics, Inc.

January 6, 2025

HistoSonics Edison® Histotripsy System Treats First Pancreatic Tumor Patients in GANNON Trial

December 16, 2024

ShiraTronics Initiates IDE Pivotal Study of Implantable Neuromodulation Therapy for Chronic Migraine

December 3, 2024

Contego Medical’s Neuroguard IEP System Receives FDA Approval for Carotid Revascularization

October 15, 2024

Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s Health

October 14, 2024

ShiraTronics Raises $66 Million in Oversubscribed Series B Financing to Advance Pioneering Treatment for Chronic Migraine

October 9, 2024

Twelve-Month Results from Landmark QUEST Study Published in Neuromodulation

September 26, 2024

category

Medtech

Status

Current

headquarters

Halifax, Nova Scotia

website

Sound Blade Medical

Sound Blade Medical is a medical device company that is developing handheld ultrasound-guided histotripsy technology to treat a wide range of conditions. Histotripsy is a non-invasive, non-thermal ablation technology to selectively destroy tissue with unparalleled precision.

category

medtech

status

Current

headquarters

Plymouth, Minnesota

website

HistoSonics

HistoSonics has developed a system to destroy tumors completely non-invasively. Treatment is achieved using histotripsy, a novel form of energy that is safe, extremely precise, and able to be personalized for each patient. The initial indication is for treatment of liver tumors and the system is being studied in several other types of tumors.

category

MEDTECH

status

Exited/Public

headquarters

Redwood City, California

website

Gynesonics

Gynesonics is a medical device company committed to advancing women’s health by developing transcervical, uterus-preserving, incisionless technologies for diagnostic and therapeutic applications. The company’s Sonata system is the world’s first and only intrauterine fibroid ablation system clinically proven to reduce fibroid symptoms across a wide range of fibroid types, sizes, and uterine locations.